BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 33531437)

  • 1. Sufficient 25-Hydroxyvitamin D Levels 2 Years after Colorectal Cancer Diagnosis are Associated with a Lower Risk of All-cause Mortality.
    Wesselink E; Kok DE; de Wilt JHW; Bours MJL; van Zutphen M; Keulen ETP; Kruyt FM; Breukink SO; Kouwenhoven EA; van den Ouweland J; Weijenberg MP; Kampman E; van Duijnhoven FJB
    Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):765-773. PubMed ID: 33531437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D, magnesium, calcium, and their interaction in relation to colorectal cancer recurrence and all-cause mortality.
    Wesselink E; Kok DE; Bours MJL; de Wilt JHW; van Baar H; van Zutphen M; Geijsen AMJR; Keulen ETP; Hansson BME; van den Ouweland J; Witkamp RF; Weijenberg MP; Kampman E; van Duijnhoven FJB
    Am J Clin Nutr; 2020 May; 111(5):1007-1017. PubMed ID: 32190892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of very low serum 25-hydroxyvitamin D
    Maalmi H; Walter V; Jansen L; Chang-Claude J; Owen RW; Ulrich A; Schöttker B; Hoffmeister M; Brenner H
    Eur J Epidemiol; 2017 Nov; 32(11):961-971. PubMed ID: 28884317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of prediagnostic vitamin D status with mortality among colorectal cancer patients differs by common, inherited vitamin D-binding protein isoforms.
    Gibbs DC; Bostick RM; McCullough ML; Um CY; Flanders WD; Jenab M; Weiderpass E; Gylling B; Gram IT; Heath AK; Colorado-Yohar S; Dahm CC; Bueno-de-Mesquita B; Perez-Cornago A; Trichopoulou A; Tumino R; Kühn T; Fedirko V
    Int J Cancer; 2020 Nov; 147(10):2725-2734. PubMed ID: 32391587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy and vitamin D supplement use are determinants of serum 25-hydroxyvitamin D levels during the first six months after colorectal cancer diagnosis.
    Wesselink E; Bours MJL; de Wilt JHW; Aquarius M; Breukink SO; Hansson B; Keulen ETP; Kok DE; van den Ouweland J; van Roekel EH; Snellen M; Winkels R; Witkamp RF; van Zutphen M; Weijenberg MP; Kampman E; van Duijnhoven FJB
    J Steroid Biochem Mol Biol; 2020 May; 199():105577. PubMed ID: 31917319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
    Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer.
    Ng K; Meyerhardt JA; Wu K; Feskanich D; Hollis BW; Giovannucci EL; Fuchs CS
    J Clin Oncol; 2008 Jun; 26(18):2984-91. PubMed ID: 18565885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial.
    Ng K; Nimeiri HS; McCleary NJ; Abrams TA; Yurgelun MB; Cleary JM; Rubinson DA; Schrag D; Miksad R; Bullock AJ; Allen J; Zuckerman D; Chan E; Chan JA; Wolpin BM; Constantine M; Weckstein DJ; Faggen MA; Thomas CA; Kournioti C; Yuan C; Ganser C; Wilkinson B; Mackintosh C; Zheng H; Hollis BW; Meyerhardt JA; Fuchs CS
    JAMA; 2019 Apr; 321(14):1370-1379. PubMed ID: 30964527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer.
    Ng K; Wolpin BM; Meyerhardt JA; Wu K; Chan AT; Hollis BW; Giovannucci EL; Stampfer MJ; Willett WC; Fuchs CS
    Br J Cancer; 2009 Sep; 101(6):916-23. PubMed ID: 19690551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance).
    Fuchs MA; Yuan C; Sato K; Niedzwiecki D; Ye X; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Venook A; Innocenti F; Warren RS; Bertagnolli MM; Ogino S; Giovannucci EL; Horvath E; Meyerhardt JA; Ng K
    Ann Oncol; 2017 Jun; 28(6):1359-1367. PubMed ID: 28327908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of vitamin D with survival in colorectal cancer patients depends on antioxidant capacity.
    Boakye D; Jansen L; Schöttker B; Jansen EHJM; Halama N; Maalmi H; Gào X; Chang-Claude J; Hoffmeister M; Brenner H
    Am J Clin Nutr; 2021 Jun; 113(6):1458-1467. PubMed ID: 33740035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Predictors of Circulating 25-Hydroxyvitamin D and Prognosis after Colorectal Cancer.
    Neumeyer S; Butterbach K; Banbury BL; Berndt SI; Campbell PT; Chlebowski RT; Chan AT; Giovannucci EL; Joshi AD; Ogino S; Song M; McCullough ML; Maalmi H; Manson JE; Sakoda LC; Schoen RE; Slattery ML; White E; Win AK; Figueiredo JC; Hopper JL; Macrae FA; Peters U; Brenner H; Hoffmeister M; Newcomb PA; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2020 Jun; 29(6):1128-1134. PubMed ID: 32188599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inverse association between serum 25-hydroxyvitamin D and mortality may be modified by vitamin A status and use of vitamin A supplements.
    Schmutz EA; Zimmermann MB; Rohrmann S
    Eur J Nutr; 2016 Feb; 55(1):393-402. PubMed ID: 25701092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance).
    Yuan C; Sato K; Hollis BW; Zhang S; Niedzwiecki D; Ou FS; Chang IW; O'Neil BH; Innocenti F; Lenz HJ; Blanke CD; Goldberg RM; Venook AP; Mayer RJ; Fuchs CS; Meyerhardt JA; Ng K
    Clin Cancer Res; 2019 Dec; 25(24):7497-7505. PubMed ID: 31548349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer in the Nurses' Health Study.
    Song M; Konijeti GG; Yuan C; Ananthakrishnan AN; Ogino S; Fuchs CS; Giovannucci EL; Ng K; Chan AT
    Cancer Prev Res (Phila); 2016 Aug; 9(8):664-72. PubMed ID: 27246684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediagnostic 25-Hydroxyvitamin D in Association with Cancer-specific and All-cause Mortality among Low-income, Non-Hispanic Black Americans with Colorectal Cancer.
    Lawler TP; Khankari NK; Shu XO; Steinwandel M; Cai Q; Jurutka PW; Zheng W; Warren Andersen S
    Cancer Epidemiol Biomarkers Prev; 2023 Aug; 32(8):1061-1068. PubMed ID: 37257199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of serum vitamin D and cancer mortality in the United States.
    Freedman DM; Looker AC; Chang SC; Graubard BI
    J Natl Cancer Inst; 2007 Nov; 99(21):1594-602. PubMed ID: 17971526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study.
    Drechsler C; Verduijn M; Pilz S; Dekker FW; Krediet RT; Ritz E; Wanner C; Boeschoten EW; Brandenburg V;
    Nephrol Dial Transplant; 2011 Mar; 26(3):1024-32. PubMed ID: 20947538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D Status and Risk of All-Cause and Cause-Specific Mortality in a Large Cohort: Results From the UK Biobank.
    Fan X; Wang J; Song M; Giovannucci EL; Ma H; Jin G; Hu Z; Shen H; Hang D
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32620963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults.
    Ginde AA; Scragg R; Schwartz RS; Camargo CA
    J Am Geriatr Soc; 2009 Sep; 57(9):1595-603. PubMed ID: 19549021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.